Abstract Cefepime (Maxipime®, Maxcef®, Cepimax®, Cepimex®, Axepim® 1), a parenteral
fourth-generation cephalosporin, is active against many organisms causative in pneumonia …

Resistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/
sulbactam and piperacillin/tazobactam in Escherichia coli (n= 438) Klebsiella pneumoniae …

Antibiotic resistance is an increasing global problem. Surveillance studies are needed to
monitor resistance development, to guide local empirical therapy, and to implement timely …

TEM-and SHV-derived extended-spectrum β-lactamases (ESBLs) producing
Enterobacteriaceae have been reported from throughout the world, but there has been …

Hospital-acquired urinary tract infection (UTI) is the most common infection acquired in
hospitals. The aim of the study was to determine the prevalence of UTIs in Turkey. A …

PER-1 type β-lactamases were screened among ceftazidime-resistant clinical isolates of
Acinetobacter spp. and Pseudomonas aeruginosa. A total of 176 non-repetitive isolates (84 …

Purpose: To study the prevalence of TEM-, SHV-and GES-type β-lactamases among
Escherichia coli and Klebsiella pneumoniae strains having ceftazidime MICs higher than 2 …

Antibiotic resistance among Gram-negative rods (GNRs) causing hospital-acquired
infections poses a threat, particularly to intensive care unit (ICU) patients. This study was …

The purpose of this study was to investigate the antimicrobial resistance pattern among
common Gram-negative bacilli isolated from patients with nosocomial infection. A total of …

The objective is to investigate the trend of antimicrobial resistance among nosocomial Gram-
negative bacteria isolated from intensive care units in China. From 1996 to 2002, the …